Search Results

Saama today announced a newly expanded, multi-year agreement with global biopharmaceutical leader Pfizer to help expedite clinical research.

Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, announced a multi-year agreement with global biopharmaceutical leader AstraZeneca.

Saama Technologies, LLC. (“Saama”) today announced that Vivek Sharma has joined the company as Chief Executive Officer (CEO).

Saama Technologies, LLC. (“Saama”) today announced that life science industry sales and marketing expert Andrew J. (AJ) Mills has been appointed as the company’s Chief Commercial Officer, effective August 15, 2022.

Saama Technologies, LLC. (“Saama”) today announced a multi-year agreement with Merck, known as MSD outside the United States and Canada, to build and operationalize a new clinical data layer leveraging Saama’s Life Science Analytics Cloud (LSAC) to strengthen Merck’s clinical development capabilities and expedite pipeline progress.

Life sciences solutions company Saama has hired Clinton White, Ph.D., MBA, to serve as Chief Delivery Officer.

Saama Technologies, Inc. (“Saama”) announced today the company’s support for the AWS for Health initiative from Amazon Web Services (AWS).

Scott brings a unique combination of financial and clinical fused with growth experience to Saama.

Saama Technologies secured a $430 million investment from the Carlyle Group and venture funds from some of the pharmaceutical industry’s biggest companies.

After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the regulator’s radar.